CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company’s lead development candidate is ...
Managing the complexities of today’s hybrid infrastructures are among those innovation inhibitors. In this webcast from Suse, featuring a guest speaker from IDC, we’ll explore how standardizing on an ...
To help you effectively understand and manage the finances of your small business, we've tested the top accounting software based on customization, features, ease of use, value, and more. I’ve been ...
When the IBM PC was new, I served as the president of the San Francisco PC User Group for three years. That’s how I met PCMag’s editorial team, who brought me on board in 1986. In the years since that ...
About CERo Therapeutics Holdings Inc. CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its ...
¿Cuál es el periodo durante el que estará abierto el plazo de presentación de solicitudes de la línea 1, es decir, cuál es el periodo de la convocatoria 2024-2026 de la línea 1 de la Orden de 29 de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results